Background With more than two-thirds of the US population overweight or obese, the obesity epidemic is a major threat for population health and the financial sustainability of the healthcare service. Whether, and to what extent, effective prevention interventions may offer the opportunity to 'bend the curve' of rising healthcare costs is still an object of debate. Objective This study evaluates the potential economic impact of a set of prevention programmes, including education, counselling, long-term drug treatment, regulation (e.g. of advertising or labelling) and fiscal measures, on national healthcare expenditure and use of healthcare services in the USA. Study Design and Method The study was carried out as a retrospective evaluation of alternative scenarios compared with a 'business as usual' scenario. An advanced econometric approach involving the use of logistic regression and generalized linear models was used to calculate the number of contacts with key healthcare services (inpatient, outpatient, drug prescriptions) and the associated cost. Analyses were carried out on the Medical Expenditure Panel Survey (1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010). Results In 2010, prevention interventions had the potential to decrease total healthcare expenditure by up to $US2 billion. This estimate does not include the implementation costs. The largest share of savings is produced by reduced use and costs of inpatient care, followed by reduced use of drugs. Reduction in expenditure for outpatient care would be more limited. Private insurance schemes benefit from the largest savings in absolute terms; however, public insurance schemes benefit from the largest cost reduction per patient. People in the lowest income groups show the largest economic benefits. Conclusion Prevention interventions aimed at tackling obesity and associated risk factors may produce a significant decrease in the use of healthcare services and expenditure. Savings become substantial when a long-term perspective is taken.
Children have not been spared, with up to one in three currently overweight [1] . Obese people have a shorter life expectancy than people of normal weight [2] and are more likely to develop diseases such as diabetes, cardiovascular diseases and cancer [3] [4] [5] . This strong association between obesity and chronic diseases suggests that obese people have an increased use of healthcare. Everything else being equal, an obese person incurs at least 25 % higher healthcare expenditures than a person with normal weight [6] . Previous studies carried out in the USA suggest that, between 2006 and 2008, the additional annual medical costs caused by obesity could be as high as $US1270 for an obese man and $US2530 for an obese woman [7] .
Obesity has risen to the top of the US and world public health policy agenda. In the USA, for example, the White House launched the 'let's move' campaign [8] , while international organizations like the Organisation for Economic Co-operation and Development (OECD) and the World Health Organization (WHO) increasingly focused their work on the health and economic assessments of policies to tackle obesity and related chronic diseases [9, 10] . Changes in food supply and eating habits, combined with a dramatic fall in physical activity, have been blamed, among others, as key drivers of the obesity epidemic [11] . Work by OECD and WHO identified a set of primary prevention policies of demonstrated effectiveness in improving diets and increasing physical activity in a wide range of countries, at different levels of income [12, 13] . Other analyses have concluded that long-term drug treatments can produce substantial long-term weight loss [14] .
Priority must be given to interventions that provide the largest health returns for the money spent, particularly when resources are made even tighter by reduced economic growth and public finance constraints. In particular, the recent healthcare reform debate has heightened interest in the potential for national medical cost savings from investment in public health and disease prevention [15, 16] .
The objective of this study is to evaluate the potential impact of a comprehensive set of obesity-prevention programmes on national healthcare expenditure and use of healthcare services in the USA. In addition, the study compares the impact of prevention programmes with those of long-term pharmacological treatment programmes for obese patients.
Methods

Methodological Overview
The study was carried out as a retrospective evaluation of alternative scenarios reflecting the hypothetical implementation of prevention policies aimed at decreasing levels of body weight in the US population. The analysis was carried out in two steps. The first involved the development of an econometric approach to model the use of healthcare resources (i.e. prescriptions of drugs/medical supplies, inpatient stays and non-inpatient visits) and the related costs. This represents the current situation under a 'business as usual' scenario. The number of healthcare resources (i.e. services) and the associated costs were then calculated again in the second phase, replacing the original BMI with a counterfactual lower BMI resulting from the implementation of the prevention policies under study. The comparison (i.e. the difference) of the two scenarios allows the calculation of the savings that would be associated with the implementation of prevention interventions under the assumption that the reduction of BMI would affect the use of healthcare services and associated expenditures through a reduction of the prevalence or the seriousness of chronic diseases linked to overweight and obesity. Similar approaches have been used elsewhere to calculate potential savings from hypothetical interventions aimed at decreasing the weight of children [17] , or the prevalence of chronic diseases [18] , or at incentivizing the substitution of brandnamed drugs with generics [19] .
Data
The primary data for the analysis were extracted from the 1997-2010 annual reports of the Medical Expenditure Panel Survey (MEPS) [20] . MEPS is an ongoing annual survey that collects data on healthcare utilization, health costs/expenditure, insurance coverage and source of payment for the US civilian non-institutionalized population. For each individual/record, MEPS reports data on demography, educational level, employment status, access to healthcare and health status. Data to calculate the BMI of adults are only available since 2000. MEPS waves before 2000 were included in the analysis as they contribute to the estimation of coefficients while they do not influence the analyses for adults that refer to the period 2000-2010. Each panel and year is representative, if the opportune weights are applied, of the US national population. Single-year datasets have been pooled and records for each survey component-inpatient visits, outpatient visits, office-based visits, emergency-room access and pharmaceutical expenditures-have been combined. Nominal expenditures and charges are expressed in $US, year 2010 values using event-specific product price indexes retrieved from the Office of the Actuary of the Centers for Medicare and Medicaid Services [21] . In particular, the hospital care price index was used for hospital outpatient visits, emergency room visits and inpatient hospital stay; the consumer price index for prescription drugs was used for drugs/ medical supplies and the composite index for physician and clinical services was used for office-based visits [22] .
Econometric Approach
Total annual medical expenditure is calculated as the combination of the predicted number of contacts for each healthcare service and the average cost per healthcare contact. This approach is based on the following algorithm:
where TOTEXP is the predicted annual expenditure, Pr represents the probability of contact during the year with, respectively, inpatient services (INP), outpatient services (OUTP) and drug prescription (DRU) and is calculated with a logistic regression model; N represents the number of predicted use of healthcare resources conditional on a positive probability of use of healthcare resources, again by healthcare service, and is calculated with a generalized linear model (GLM) with log link and Gamma distribution for DRU and INP and with log-link and Poisson distribution for OUTP. EXP represents the predicted annual medical expenditure for a single use of a healthcare service conditional on the positive probability of use of the healthcare service and is calculated with a GLM with log link and Gamma distribution for all the healthcare services. This econometric approach was selected after assessment against an extensive set of approaches retrieved from the literature. The performances of all the models were assessed by employing the standard set of criteria employed by Manning and Mullahy [23] , implemented with an additional set of tests [24] [25] [26] [27] . A description of the process and key results can be found in the Electronic Supplementary Material.
For each of the GLM models, the selection of the dependant variable and the link function to determine the relation between the dependent variable and the explanatory variables followed a two-step approach. In a first phase, the Box-Cox test [28] was first used to determine the relationship between xb and f(y | x) and, therefore, the selection of the link. In a second step, following the approach employed by Trasande and Chatterjee [29] , the Akaike information criterion [30, 31] approach was used to select the best fitting combination of log link and distribution families. The distribution families tested included Gaussian, inverse Gaussian, binomial, Poisson, negative binomial and Gamma.
Dependent and Explanatory Variables
The utilization and the cost of each of the three categories of healthcare services (i.e. drugs/medical supplies, inpatient services and outpatient services) is modelled as a function of three dependent variables: (1) use of the service; (2) the number of accesses; and (3) the average cost per access. For each individual record, MEPS provides the total number of accesses by service and the associated total cost per year. The probability of access is dichotomised as 1 for at least one access or 0 otherwise. The average expenditure per access is calculated as the ratio between total expenditure and the number of accesses. Inpatient services include inpatient visits and emergency room access, while outpatient services include hospital outpatient and office-based visits.
Estimating equations for the nine models (i.e. three models for each of the three healthcare services) include the following explanatory covariates (x SD ): survey year, sex, age, race, level of education, family income (as percentage of the poverty line), insurance coverage (private, public, uninsured), marital status, region of residence and personal BMI.
In addition, as our objective was to calculate the cost for specific diseases, the models include covariates for (x D ) possible diagnosed medical conditions, including hypertension, hypercholesterolemia, diabetes, ischaemic heart disease, stroke, colorectal cancer, lung cancer and breast cancer and other comorbidities that have been recognized as closely associated with overweight or obesity [32, 33] . Following previous studies, covariates also include self-assessed health status (five categories: excellent to poor) to capture complex interactions between comorbidities [34] [35] [36] [37] [38] .
A final vector of variables was specific for the models predicting the average expenditure per contact with the healthcare system. The inpatient model included dimensions associated with the type and the quantity of healthcare services that were used by patients. This vector (x INP ) includes the number of accesses to inpatient services in the year, the number of nights spent in the hospital, whether surgery was performed and whether the patient was admitted to the emergency room. The two vectors for outpatient services (x OUTP ) and drug consumption (x DRU ) only include the number of services accessed during the year.
More formally, the specifications of the nine equations are as follows:
Probability of positive contact with specific healthcare services:
where the contact with the specific healthcare service is positive if Pr i [ 0 and the contact with the healthcare service is 0 otherwise. Predicted number of contacts with specific healthcare services:
Predicted average cost per contact with specific healthcare services:
Effects of the Interventions
Nine different interventions were assessed, namely, schoolbased health promotion interventions, worksite health promotion interventions, counselling of individuals at risk in primary care (with and without follow-up counselling by a dietician), regulation of food advertising to children (either compulsory or self-regulated by the industry), compulsory food labelling; fiscal measures increasing the price of sugar-sweetened beverages (SSB) by 10 %; and longterm drug treatment for obesity. Evidence to model the effectiveness of the interventions has been retrieved from previous comprehensive reviews [9, 10, 12, 14, 39, 40] . A summary of the characteristics and the effectiveness of interventions can be found in Table 1 .
Interventions directly affect the use of healthcare services and associated healthcare expenditures by decreasing the BMI of targeted individuals as well as their risk of having one of the considered health conditions. In particular, the effect of the interventions on the outcome variables (i.e. probability, number and expenditure of healthcare interventions) has been studied by assuming that an intervention would produce a decrease in the BMI of target individuals equal to the figures reported in Table 1 . Concurrently, the BMI reduction would also produce a decrease in the risk of chronic diseases associated with overweight and obesity that was calculated on the same MEPS dataset by applying linear univariate regressions. Interventions may affect the BMI in the short-term (i.e. the target individual is undergoing the intervention) or in the long term (i.e. part of the effectiveness of the intervention is retained after its end). In particular, for the interventions affecting adults, individuals were assumed to return to their previous BMI in the year following the end of the intervention (i.e. long-term effect on BMI = 0). The coverage/compliance with the interventions is incorporated in the analyses by multiplying the effect on BMI and the compliance rate. So, for example, when school-based interventions are implemented, any child aged 8-9 years has a decrease in BMI of 0.188 kg/m 2 (i.e. 0.2994 %) and maintains a BMI decreased by 0.094 kg/m 2 (i.e. 0.1994 %) for the rest of their life. As the relationship between BMI and cost/use of healthcare services is modelled in a linear fashion, this has the same effect at the population level, of decreasing the BMI by 0.2 to a random 94 % of the concerned population subgroups. Table 2 represents summary statistics for the whole MEPS datasets and for the first and last year included in the analyses. Underlying trends are clear for most of the variables involved in the estimations. In particular, the population tends to become older and BMI increases over time. The prevalence of those covered by private insurance decreases (from 73.0 to 65.0 %), while public health insurance schemes cover an increasingly large share of the population (from 14.6 % in 1997 to 21.9 % in 2010). The prevalence of people with no health insurance remains stable at around 12.3 % of the population sample. The prevalence of all the considered diseases increases, as does the average number of comorbidities reported by patients. No statistically significant change was observed for prevalence of those reporting zero health expenditure, but the average health expenditure more than doubled between 1997 and 2010 ($US2039 vs. $US4094).
Results
Descriptive Analysis
Total Savings and Savings Stratified by Healthcare Services in 2010
In 2010 alone, interventions such as long-term drug treatment for obesity or physician-dietician counselling in a primary care setting would decrease total healthcare expenditure by more than $US2 billion, which is about $US8.3 per resident or, respectively, $US100 and $US70 per beneficiary of the intervention (Fig. 1) . Regulation of food advertising to children is the third most effective intervention, with expected savings of about $US1.6 billion. A tax on SSB, workplace interventions, and compulsory food labelling are the interventions that return the lowest savings, with an expected economy of between $US89 and 212 million. Decrease of inpatient expenditure accounts for about two-thirds of total savings, ranging between 60.6 % (longterm drug treatment for obesity) and 71.8 % (workplace interventions). Any surgical intervention is the single component responsible for the largest decrease in inpatient expenditure. Everything else being equal, the average additional cost for a hospitalization with surgical intervention is about $US1989 but, for instance, it can be as high as $US7343 for patients with higher BMI and multiple risk factors. Our results show that prevention interventions decrease both the probability and the average cost associated with a surgical operation.
Prescription of drugs/medical supplies is generally the second driver of reduction of expenditures, accounting for about 30 % of the total savings. Despite the positive effect that prevention has on the average cost of inpatient and outpatient care, preventive interventions do not reduce the average cost per prescription. Indeed, with increased implementation of preventive measures, the average cost per prescription increases slightly-on average, this ranges between $US0.005 (compulsory food labelling) and $US0.14 (physician-dietician counselling in a primary care setting). However, the average additional cost per prescription is more than offset by the lower number of prescriptions.
Reduction of outpatient expenditure makes up only between 2.2 % (workplace interventions) and 4.2 % (longterm drug treatment for obesity) of the decrease of total healthcare expenditure. In fact, everything else being equal, the average cost associated with outpatient care does not show particular variation across the BMI distribution. For example, the expenditure for episode of outpatient care for the average person with a BMI = 20 is only $US11.3 lower than the outpatient care expenditure for an average person with a BMI of 45 ($US239.4 vs. 250.7). Additionally, for administrative reasons (e.g. the cost of post-operative outpatient follow-up tends to be bundled with inpatient costs), some of the savings associated with reduced outpatient care are included as inpatient expenditure.
Costs Over Time
An early implementation of the prevention interventions would have produced a remarkable cut of health expenditure in the period 2000-2010. Figure 2 reports the cumulative savings in healthcare expenditure over time; results are not discounted and are reported in $US, year 2010 values. Figure 3 , instead, reports the cumulative savings discounted at a 3 % rate. Both Figs 2 and 3 do not take into account the cost of delivering the interventions. Up to $US18 billion ($US15 billion if discounted) could have BMI body mass index, BP blood pressure, DM diabetes mellitus, SSB sugar-sweetened beverages Preventing Obesity in the USAbeen saved with the introduction of a programme of physician-dietician counselling in primary care. Slightly lower, but still extremely significant, savings could have been produced by long-term drug treatments for obese people and regulation of food advertising to children.
Expenditure Reductions by Payer
Overall, private health insurance would have the highest return from the implementation of preventive interventions (Fig. 4) . Across all the interventions, on average, almost 60 % of total savings would come from decreased expenditure by private healthcare insurance (minimum 56.1 % for regulation of food advertisement to children, maximum 66.1 % for workplace interventions). In 2010, compared with a 'business as usual' scenario, public insurance schemes (e.g. Medicare and Medicaid) would, instead, benefit from savings of between $US36 million (compulsory food labelling scheme) and $US851 million (longterm drug therapy). Finally, implementation of preventive interventions would have had, overall, a more contained effect for the uninsured population, with savings that vary between $US2.6 million (compulsory food labelling schemes) and $US117.7 million (physician-dietician counselling in primary care). However, when the average effect per patient was considered, public insurance showed the largest gains. Across all the interventions, the average case covered by public insurance shows savings that were up to twice as large as those experienced, for the same interventions, by 
Use of Healthcare Services
The impact of prevention interventions on the use of healthcare services is substantial, particularly in terms of number of prescriptions of drugs/medical supplies (Fig. 5) . In 2010 alone, physician-dietician counselling would decrease the number of drug/medical supplies prescriptions by $US16.7 million. Long-term drug therapy for obesity and regulation of food advertising to children follow, with, respectively, a potential decrease of 15.4 and 11.3 million prescriptions. The use of other healthcare services would also be reduced, albeit to a minor extent. In 2010, the number of outpatient visits would decrease by between 38,000 (compulsory food labelling) and 1.1 million (physician-dietician counselling). In the same year, the number of inpatient admissions would decrease by between 4500 (compulsory food labelling) and 125,300 (physician-dietician counselling). 
Discussion
This study advances the economic literature on the modelling of healthcare expenditure and the use of healthcare services. The use of a novel econometric approach allowed us to calculate the potential impact on the use of a full range of healthcare services and costs associated with the implementation of prevention interventions aimed at tackling obesity and related chronic diseases. In particular, the use of an econometric model involving nine steps enabled us to disentangle the contribution of key healthcare services to overall health expenditure along with different dimensions, such as, for example, who pays for the healthcare service. What is even more interesting is that these additional features of the modelling approach did negatively impact on the predictive performance of the model. Several studies have investigated the relationship between overweight and medical costs [41, 42] . However, to our knowledge, no study has evaluated the potential savings associated with the implementation of innovative prevention practices in the USA. This study particularly compares the population impact on healthcare expenditure for primary, secondary, and tertiary prevention policies. Prevention interventions may produce significant savings at the population level. Such savings become substantial when a long-term perspective (i.e. a multi-year Results of this study have important implications for policy making at the national level. One of the challenges that looms large after the passage of healthcare reform is whether, and at what political cost, the USA will be able to contain healthcare costs in the long run [43, 44] . Results from our analysis indicate that the expansion of screening and counselling for obesity-which is already included as a key element of the Affordable Care Act [45] -can play a critical role in containing healthcare costs. The inclusion of this intervention with other policies in a more comprehensive prevention package could provide a remarkable contribution to 'bending the curve' of rising healthcare costs.
Health insurance schemes in particular may have strong financial incentives to support the adoption of obesityprevention policies that fall outside the health domain, such as, for example, fiscal measures or regulation of advertising. Contrary to extending screening and counselling programmes, the cost of which would inevitably be borne by health insurance schemes, the cost of implementing and managing these programmes would be completely external to the budget of healthcare insurance schemes, while they would benefit from the reduction of health expenditure.
Prevention programmes show a more limited effect on healthcare expenditure for the uninsured population.
Compared with those covered by healthcare insurance, uninsured people tend to forego necessary healthcare and, when they do access healthcare services, the average expenditure is lower. It is therefore no surprise that prevention interventions largely do not affect health expenditure for this population group.
A number of key factors may significantly affect the effectiveness of prevention policies at the population level and their consequent impact on healthcare expenditure. Among these are, for example, the ability of the intervention to generate sustained changes in people's behaviours, and the extent to which individuals targeted by interventions respond. Our analyses adopted a very conservative approach, assuming that adult individuals revert to their previous behaviours and BMI after the end of the intervention. This means that reduced expenditure in a given year-for example, in 2010-is the only effect of reduced healthcare use for adults who were targeted by an intervention in that year. In the case of interventions affecting children, this rule relaxed somewhat, and we assume that 50 % of the effectiveness of the intervention on children is retained for the rest of the individual's life. This is defined in Table 1 as 'long-term effects of the intervention'. The underlying assumption of our analyses is that interventions targeting children would have been implemented sufficiently long before the studied period that the intervention had already reached the steady state (i.e. the moment in time in which the intervention covers the full potential population target). In other words, we assume that all the adult population in any given year had already undergone the intervention(s) when they were children.
Another factor that may significantly increase the overall effectiveness of an intervention is the population coverage. Even the most comprehensive prevention programmes generally struggle to reach a sizable proportion of the population and generate a change in health-related behaviours. In some cases, appropriate measures can be taken to increase coverage and uptake [46] . Ensuring a meaningful uptake in community-based programmes can be even more challenging. This is clearly demonstrated by the performances of interventions like food labelling schemes or workplace interventions [54-58, 64, 65] . The design of the econometric approach was a very strong point of this study and yields some insights into the mechanisms underlying the reduction in use of healthcare services and the associated cost reduction. Most of the savings are due to a reduced expenditure for hospital admissions, with lower costs and likelihood of surgical operations as key drivers of the reduction.
Conversely, it is beyond the scope of this study to carry out a full cost-benefit analysis, and, therefore, our evaluation does not account for the cost of implementing the prevention interventions. Most of the interventions considered in the study fall outside the domain of payers for healthcare services, private and public health insurance schemes included, which is the perspective used in this analysis. For example, interventions like food-labelling schemes or regulation of advertising would essentially require government funding to be designed, legislated and enforced. If we were to evaluate the cost of only interventions that can be fully delivered by health insurance schemes (e.g. physician counselling or long-term drug treatment), the resulting analysis would constitute an unfair comparison of the different interventions, and its findings may be misleading due to the high heterogeneity of agreements between different insurance schemes and providers of healthcare services.
Some limitations of this study should be noted. A significant part of the MEPS records are based on self-reported information. Recall error or imperfect understanding of key questions may mean that some entries may not accurately reflect reality; this may affect the results of this study. For example, other analyses have found that MEPS data tend to underestimate total medical expenditure by about 18 % [47] . This limitation of the dataset would lead to a likely underestimation of the actual cost savings associated with the implementation of primary prevention policies in the USA. Thus, results presented here are likely to be conservative. Another potential source of bias may be introduced by various healthcare payment recording practices. In a number of cases (e.g. some follow-up visits after hospitalization), the costs associated with outpatient care are accounted for in the inpatient care costs. Therefore, for all these cases, any potential saving is categorized as a saving in inpatient care and not in the outpatient care category. A final source of uncertainty derives from the parameters used to model the effectiveness of the interventions. Interventions are modelled, as far as possible, on systematic reviews or large-scale studies. However, for a number of policies, the body of evidence on the effectiveness and, in particular, on the long-term effectiveness of the interventions needs to be further developed. We therefore decided to limit the study only to some policies for which the body of evidence is more developed. In addition, for the modelled policies, we decided to adopt the conservative assumption of no long-term effectiveness on adult population.
Finally, this study is not designed to quantify the impact of prevention policies on non-medical costs as, for example, absence from work due to illnesses or costs associated with presenteeism. These savings may be substantial and might overshadow any current estimates of medical and pharmacy cost savings [7, 48, 49] . Future research is warranted on effective preventive measures aimed at reducing absenteeism and presenteeism in relation to the obese and overweight workforce.
Conclusion
This study suggests that a wide range of interventions aimed at reducing BMI in the US population have the potential to produce a meaningful impact on the use of healthcare services and associated expenditures.
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